Article Text

Download PDFPDF
EAHP President Joan Peppard advises members to heighten their awareness of the Falsified Medicines Directive in 2016
  1. Richard Price
  1. Correspondence to Richard Price, Policy and Advocacy, European Association of Hospital Pharmacy, 3 Rue Abbe Cuypers, Brussels, Brussels 1040, Belgium; richard.price{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Writing to national member associations, EAHP President Joan Peppard has encouraged hospital pharmacists in all EU and European Economic Area (EEA) countries to take time to familiarise themselves with the forthcoming impacts to practice arising from the 2011 Falsified Medicines Directive and ensure hospital pharmacy representation at the national level on the issue.

The Directive will bring about a new system in which all packages of medicine will be given a ‘unique identifier’ via a two-dimensional (2D) barcode on the outer packaging. This will be placed on the packaging at the manufacturing level, and the serialisation code then ‘checked in’ to a repository marking the package as legitimate. Importantly for hospital pharmacy, this code must then be ‘checked out’ at the end of the supply chain, before the medicine is dispensed or administered to patients. This scan both assures the pharmacist that the product is not counterfeit, while the …

View Full Text


  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.